Status:
COMPLETED
Behavioral Nudges to Improve Palliative Care Utilization in Advanced Cancer
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Conditions:
Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with cancer often undergo costly therapy and acute care utilization that is discordant with their wishes, particularly at the end of life. Despite early palliative care consultations being a ...
Detailed Description
Patients with advanced cancer have poor quality of life and life expectancy. Palliative care is a medical specialty focusing on providing relief from the symptoms and stress of serious illnesses such ...
Eligibility Criteria
Inclusion
- Have a functional telephone number
- Receive ongoing care from hematology/oncology services within the Ann B. Barshinger Cancer Institute (ABBCI) at Lancaster General Health.
Exclusion
- Patients appearing for a new patient visit
- Patients who have previously received palliative care
- Patients who are enrolled in an ongoing clinical trial of a therapeutic agent
- Patients who receive primary oncologic care within another institution
Key Trial Info
Start Date :
May 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2023
Estimated Enrollment :
266 Patients enrolled
Trial Details
Trial ID
NCT05365997
Start Date
May 23 2022
End Date
August 8 2023
Last Update
February 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ann B. Barshinger Cancer Institute at Lancaster General Health
Lancaster, Pennsylvania, United States, 17601